BG
ACH

Bahl & Gaynor’s Accendra Health ACH Stock Holding History

Bahl & Gaynor’s Portfolio ACH Stock Details ACH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-10,110
Closed -$342K – 452
2015
Q1 		$342K Buy
10,110
+190
+2% +$6.62K ﹤0.01% 360
2014
Q4 		$348K Buy
9,920
+1,020
+11% +$34.3K ﹤0.01% 343
2014
Q3 		$291K Sell
8,900
-4,474
-33% -$152K ﹤0.01% 366
2014
Q2 		$454K Buy
13,374
+620
+5% +$21.2K 0.01% 288
2014
Q1 		$447K Buy
12,754
+1,120
+10% +$39.5K 0.01% 285
2013
Q4 		$425K Buy
11,634
+1,085
+10% +$39.8K 0.01% 286
2013
Q3 		$365K Buy
10,549
+350
+3% +$12.2K 0.01% 290
2013
Q2 		$345K Buy
+10,199
New +$339K 0.01% 285

Other funds holding ACH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bahl & Gaynor's ACH Position: Q2 2015 in Review

Bahl & Gaynor sold out of Accendra Health (ACH) in Q2 2015, closing a stake of 10,110 shares — an estimated $342K sold.

Bahl & Gaynor first reported a position in ACH in Q2 2013 and held it in 8 quarters. The position peaked at $454K in Q2 2014. 239 funds tracked by Wall St. Rank hold ACH as of Q2 2015.

  • Bahl & Gaynor reported no remaining Accendra Health position as of Q2 2015 after selling out during the quarter.
  • Bahl & Gaynor sold 10,110 Accendra Health shares in Q2 2015, an estimated $342K.
  • Bahl & Gaynor first reported a position in Accendra Health in Q2 2013 and held it in 8 quarters.
  • Bahl & Gaynor's Accendra Health position peaked at $454K in Q2 2014.
  • 239 funds tracked by Wall St. Rank held Accendra Health as of Q2 2015.

Based on Bahl & Gaynor's 13F filing for Q2 2015, filed 3 Aug 2015.